Navigation Links
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions
Date:5/25/2011

THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists in the United States (U.S.). Eighteen abstracts across four indications, including moderate-to-severe rheumatoid arthritis (RA), ankylosing spondylitis (AS), moderate-to-severe plaque psoriasis (PsO), and psoriatic arthritis (PsA), will be published at two global medical congresses, the European League Against Rheumatism (EULAR) and World Congress of Dermatology (WCD), this week.

"The breadth of data being presented at these congresses underscores our ongoing commitment to the rigorous study of these conditions where treatment has been shown to improve patient outcomes," said Yvonne Greenstreet, senior vice president and head of the Medicines Development Group for Pfizer's Specialty Care Business Unit. "With its first approval for RA in 1998, ENBREL has 2.5 million patient-years of collective clinical experience, and we continue to gain important knowledge about these conditions and the potential benefits of treating patients with certain chronic inflammatory diseases."

Selected abstracts of interest include:

Rheumatoid ArthritisImpact of Etanercept-Methotrexate (MTX) Therapy on Disease Activity and Radiographic Progression in Moderately Active Rheumatoid Arthritis: Interim Results of the PRESERVE Trial Persistent inflammation and associated joint damage may play a critical role in causing impairment in joint function in RA. Previous studies exploring treatment with biologics focused primarily on patients with severe disease. The radiographic data are an exploratory end
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 The new report ... (products, applications, techniques, end users and Geography) Global ... 2013 - 2020," indicates that the global DNA ... registering a CAGR of 9.8% from 2014 to ... cost effectiveness over alternative diagnostic techniques are factors ...
(Date:8/28/2014)... 2014  Seres Health, a clinical-stage therapeutics company ... human microbiome, announced today that Dr. David ... and Chief Scientific Officer, will be presenting at ... Chemotherapy (ICAAC). The presentation will highlight the scientific ... of bacterial spores derived from the human microbiome, ...
(Date:8/28/2014)... -- Gateway Analytical announced today that they will ... Global Pharma Manufacturing Summit in Boston, ... Global Pharma Manufacturing Summit offers a networking opportunity ... pharmaceutical manufacturing. The conference is focused on helping ... as the increasing pressure to grow and evolve ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
(Date:8/29/2014)... the Fed reported an increase in industrial production ... 0.4% while manufacturing output progressed to 1.0%. , This ... February this year. Capacity use has increased by more than ... increase that could be attributed to the boost in vehicle ... a measure of slack across the industries. , Output in ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... 2014 As a chiropractic physician and ... that there’s a direct connection between the condition of ... back. "Since conventional shoe inserts and orthotics weren’t satisfying ... my own," he said. , Customizable to a user’s ... for the foot in order to help prevent pain ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Researchers have ... in their brains. Dyslexia -- the most commonly ... problems with reading and writing. Previous research showed ... but most of those studies focused only on a ... used functional MRI to analyze how multiple brain regions ...
(Date:8/29/2014)... Angeles (PRWEB) August 29, 2014 ... Radio Today at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers ... years of money, marital bliss, prodding, laughing and ... of the house this week. Relief and ... of “now what.” Dr. Carol Francis ...
Breaking Medicine News(10 mins):Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3
... MPH, an endocrinologist at Nationwide Children,s Hospital, has developed ... text messages to remind adolescent diabetes patients about their ... Dr. Dyer found an increase in overall treatment adherence ... began developing this pilot study after realizing the potential ...
... Reporter , THURSDAY, July 29 (HealthDay News) -- Although ... and ward off osteoporosis, New Zealand researchers say the supplements ... small increase in the risk for heart attack among older ... researchers suggest that people get their required calcium, if possible, ...
... CD74 is a protein that is expressed in and ... lymphocytes and antigen presenting cells. This protein is known ... immune response. Additionally, Professor Shachar,s lab has previously shown ... of the immune system, and that its stimulation by ...
... important factor, influencing both morbidity and recovery after ... allow early intervention, which may prevent later complications. ... medical evaluations to identify significant weight loss over ... thickness, serum nutritional factor levels and functional measurements ...
... (HCC) is one of the most common cancers ... of the more difficult cancers to treat. It ... A number of dietary compounds possess anti-cancer properties. ... specific targets that control cell proliferation and apoptosis. ...
... clinical medicine are familiar with learning curves, and strategies ... on clinical care. Because similar learning curves have been ... University Medical Center studied the phenomenon in the data ... point to ways to improve the quality of future ...
Cached Medicine News:Health News:Pilot study supports adolescent diabetes patients through personalized text messages 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 3Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 4Health News:How to detect malnutrition in patients effectively? 2Health News:Clinical trials can be improved by managing the learning curve 2Health News:Clinical trials can be improved by managing the learning curve 3
... Vacuum Controller V-800 Efficiently controls vacuum levels ... and off as needed to maintain preset vacuum level ... membrane vacuum pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory vacuum ...
... V-500 and water-cooled secondary condenser to trap ... powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up ... vacuum source for instruments including vacuum ovens, ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... addition to the powerful PTFE membrane vacuum pump ... achieve an ultimate vacuum of 1 mbar or ... For use with vacuum drying ovens ... from lab size up to industrial size rotary ...
Medicine Products: